<DOC>
	<DOC>NCT01499225</DOC>
	<brief_summary>This study is designed to evaluate the efficacy and the safety of YH14642 in Korea patients with chronic periodontitis, in order to investigate the recommended therapeutic dose.</brief_summary>
	<brief_title>A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Subjects must be 20 years of age or older Have at least 18 natural teeth Four or more clinical attachment level(CAL) ≥ 3mm Four or more periodontal pockets with a probing depth (PD) ≥ 4mm Have Bleeding on probing Provide informed consent and willingness to cooperate with the study protocol Forbidden History of Panax Notoginseng and Rehmanniae Radix Preparata Hypersensitivity of Doxycycline Hypersensitivity of Zea mays L. extract Critical diseases such as HIV previous three years Patients with mental retardation and dementia Systemic diseases such as diabetes and hypertension Patients who take Anticoagulants or Antiplatelet Agents Patients who have malignant tumor Smoker Continually use for 2weeks of phenytoin, calcium channel blocker, cyclosporin, coumarin, nonsteroidal antiinflammatory drugs and aspirin use in the previous one month Patients who need malignant tumor Patients who received periodontal treatment within the last 6 months Pregnant or lactating females</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>